N-acetyl-β-D-glucosaminidase (NAG)

The N-Acetyl-β-D-glucosaminidase (NAG) assay kit is for determination of NAG in urine samples.

Regulatery Status: FDA 510K, CE

Product Catalog Number Packaging Method/Format
Product Catalog No: Kit (540 Tests) Pack Size: DZ062A-K Pack Size: R1: 1 x 75 mL
R2: 1 x 15 mL
R3: 1 x 30 mL
Cal: 1 x 2 mL vial
(Calibrator Included &
Packaged Separately)
Pack Size: Colorimetric, Endpoint
Liquid Stable
Product Catalog No: Calibrator Pack Size: DZ062A-Cal Pack Size: 1 x 2 mL
Pack Size:
Product Catalog No: Control Pack Size: DZ062A-Con Pack Size: 2 x 2 mL
Pack Size:

Category:
Product Features

N-Acetyl-β-D-glucosaminidase (NAG) Assay is ready-to-use for manual methods and adaptable for analyzers. The assay is specific for NAG and has excellent sensitivity with a linear range up to 200 IU/L² and excellent precision with a CV% of <5%. There is no significant interference from hemoglobin or albumin. Interference from bilirubin occurs only at levels higher than 5 mg/dL.

Assay Principle

The reagents of the assay kit are in stable liquid formulation that allows ease of use coupled with enhanced performance characteristics. NAG hydrolyses 2-methoxy-4-(2’nitrovinyl)-phenyl 2-acetamido-2-deoxy-β-D-glucopyranoside (MNP-GlcNAc) to 2-methoxy-4-(2′-nitrovinyl)-phenol product. The product formation is detected by development of color at 505nm upon addition of an alkaline buffer.

Order Enquiry

    Order Enquiry Form

    Enquiry